Presentation "Superprofit, predetermining lobbying by pharmacological companies, amendments to the legislation of Ukraine"

In Europe and, more recently, in Ukraine, pharmacological companies have been making significant efforts to make it possible to use medicines made on the basis of the medicinal properties of hemp. Initiatives of this kind are primarily aimed at making a profit related to the sale of the “cost of a patent” for a medicine to a patient. How this problem is solved in civilized countries and why it is ten times more profitable to use food products, cosmetic preparations or biologically active / feed additives made from raw materials of therapeutic hemp, while receiving a greater healing or healing effect than from pharmacological preparations, information specialists Hemp Consulting site prepared an appropriate study.

The presentation was prepared for use in the training of students of the Hemp University, as well as a brief summary of ongoing activities related to tracking various initiatives aimed at amending the current legislation of Ukraine.

The presentation consists of the following sections:

• characteristics of the European market, which determine the potential for exponential sales growth in the short term, of medicines manufactured on the basis of the therapeutic properties of hemp;

- the reasons why the market of European countries is considered as one of the most highly liquid in the world;

- the amount of resources invested in this sector of modern hemp breeding (primarily investment);

- the potential volume of the European market for pharmacological preparations made on the basis of the therapeutic properties of hemp;

• the history of the introduction of prohibitive measures aimed at crowding out various product groups based on hemp raw materials from the market in favor of medicines manufactured on the basis of the therapeutic properties of hemp;

• the dynamics of the growth of the market for medicines manufactured on the basis of the therapeutic properties of psychoactive hemp in Europe, as exemplified by individual countries;

• the dynamics of changes in the regulatory framework governing the use of drugs manufactured on the basis of the therapeutic properties of hemp in selected European countries;

• existing and potential market volumes of hemp-based medicines in selected European countries:
- Netherlands;
- Denmark;
- Portugal;
- Greece;
- Belgium;
- Slovenia

• market potential of cannabis-based medicines in Ukraine;

• the technologies used to lobby the interests of pharmacological companies to promote changes to existing legislation in Ukraine;

• alternatives to the paradigm imposed on Ukrainian society about the need to amend the relevant laws of Ukraine used in economically developed countries;

• market potential of various groups of products using the therapeutic properties of technical hemp